Cargando…
Amylin and its analogs: a friend or foe for the treatment of Alzheimer's disease?
Amylin, a gut-brain axis hormone, and amyloid-beta peptides (Aβ), a major component of the Alzheimer's disease (AD) brain, share several features, including similar β-sheet secondary structures, binding to the same receptor and being degraded by the same protease, insulin degrading enzyme (IDE)...
Autores principales: | Qiu, Wei Qiao, Zhu, Haihao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114192/ https://www.ncbi.nlm.nih.gov/pubmed/25120481 http://dx.doi.org/10.3389/fnagi.2014.00186 |
Ejemplares similares
-
An amylin analog used as a challenge test for Alzheimer's disease
por: Zhu, Haihao, et al.
Publicado: (2017) -
Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
por: Frost, Georgia R., et al.
Publicado: (2019) -
Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment
por: Qiu, Wei Qiao, et al.
Publicado: (2014) -
Association of Plasma Amylin Concentration With Alzheimer Disease and Brain Structure in Older Adults
por: Zhu, Haihao, et al.
Publicado: (2019) -
Protein phosphorylation in neurodegeneration: friend or foe?
por: Tenreiro, Sandra, et al.
Publicado: (2014)